SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-072563
Filing Date
2024-06-18
Accepted
2024-06-18 07:11:00
Documents
20
Period of Report
2024-07-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242736d2_def14a.htm   iXBRL DEF 14A 877937
6 GRAPHIC bc_payvshareholder-4c.jpg GRAPHIC 93204
7 GRAPHIC bc_payvsnetincome-4c.jpg GRAPHIC 79151
8 GRAPHIC bc_payvsnetrevenue-4c.jpg GRAPHIC 73327
9 GRAPHIC lg_avadeltm-4clr.jpg GRAPHIC 12977
10 GRAPHIC px_24avadelpxy01pg01-4c.jpg GRAPHIC 410875
11 GRAPHIC px_24avadelpxy01pg02-4c.jpg GRAPHIC 255110
  Complete submission text file 0001104659-24-072563.txt   4119418

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20231231.xsd EX-101.SCH 9456
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avdl-20231231_def.xml EX-101.DEF 6786
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20231231_lab.xml EX-101.LAB 33110
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20231231_pre.xml EX-101.PRE 5916
23 EXTRACTED XBRL INSTANCE DOCUMENT tm242736d2_def14a_htm.xml XML 270874
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37977 | Film No.: 241050173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)